Symbol | Name | Allocation | Country | Exchange |
---|---|---|---|---|
NOVO-B | Novo Nordisk A/S | 15.03% | DK | CO |
ROG | Roche Holding AG | 14.88% | CH | SW |
AZN | Astrazeneca Plc | 14.10% | UK | LSE |
NOVN | Novartis AG | 13.18% | CH | SW |
GSK | Glaxosmithkline Plc | 4.75% | UK | LSE |
EL | EssilorLuxottica SA | 3.55% | FR | PA |
LONN | Lonza Group AG | 2.46% | CH | SW |
ALC | Alcon AG | 2.30% | CH | SW |
ARGX | Argen-X | 1.38% | BE | BR |
COLO-B | Coloplast A/S | 0.93% | DK | CO |
PHIA | Koninklijke Philips NV | 0.89% | NL | AS |
STMN | Straumann Holding AG | 0.86% | CH | SW |
SOON | Sonova H Ag | 0.86% | CH | SW |
SN | Smith & Nephew | 0.78% | UK | LSE |
QGEN | Qiagen N.V. | 0.77% | US | NYSE |
RO | Roche Holding AG | 0.69% | CH | SW |
UCB | UCB SA | 0.67% | BE | BR |
SRT3 | Sartorius Aktiengesellschaft | 0.64% | DE | XETRA |
FME | Fresenius Medical Care AG & Co. KGaA | 0.45% | DE | XETRA |
ORNBV | Orion Oyj B | 0.39% | FI | HE |